Skip to content

R Ross Maclean

2 papers in the library · 8 citations · publishing 2024

Papers

Sort Most recent Most cited

From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder.

British Journal of Clinical Pharmacology December 1, 2024 Jeremy Weleff, Julio C Nunes, Gabriel P. A. Costa et al. 8 citations

The rise of psychedelics in contemporary medicine has sparked interest in their potential therapeutic applications. While traditionally associated with countercultural movements and recreational use, recent research has shed light on the potential benefits of psychedelics in various mental health conditions. In this review, we explore the possible role of psychedelics in the management of...

DOI: 10.1111/bcp.16045 (opens in new tab) Full text (opens in new tab) Analgesia Drug development Hallucinogen Nociception +1

A preliminary investigation of the acute effects of delta-9-tetrahydrocannabinol on pain and opioid attentional bias among persons with opioid use disorder.

Journal of Psychiatric Research September 1, 2024 Noah R Wolkowicz, Mehmet Sofuoglu, Brian Pittman et al.

Attentional bias (AB) is believed to be an important factor in the development and maintenance of both opioid use disorder (OUD) and chronic pain. Cannabis and its main psychoactive constituent, delta-9-tetrahydrocannabinol (THC), produce analgesic effects via processes that are potentially relevant to AB and is commonly used by persons with OUD. This exploratory study investigated if THC...